Cardiometabolic Index, Triglyceride-glucose Index를 이용한 대사증후군 진단 예측지수에 대한 고찰: 부산지역 건강검진대상자 중심으로
Consideration of Predictive Indices for Metabolic Syndrome Diagnosis Using Cardiometabolic Index and Triglyceride-glucose Index: Focusing on Those Subject to Health Checkups in the Busan Area
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study investigates the utility of the Triglyceride-glucose(TyG) index and Cardiometabolic Index(CMI) as predictors for diagnosing metabolic syndrome. The study involved 1970 males, 1459 females, totaling 3429 participants who underwent health checkups at P Hospital in Busan between January 2023 and June 2023. Metabolic syndrome diagnosis was based on the presence of 3 or more risk factors out of the 5 criteria outlined by the American Heart Association/National Heart, Lung, and Blood Institute(AHA/NHLBI), and participants with 2 or fewer risk factors were categorized as normal. Statistical analyses included independent sample t-tests, chi-square tests, Pearson’s correlation analysis, Receiver Operating Characteristic(ROC) curve analysis, and logistic regression analysis, using the Statistical Package for the Social Sciences(SPSS) program. Significance was established at p<0.05. The comparison revealed that the metabolic syndrome group exhibited attributes such as advanced age, male gender, elevated systolic and diastolic blood pressures, high blood sugar, elevated triglycerides, reduced LDL-C, elevated HDL-C, higher Cardiometabolic Index, Triglyceride-glucose index, and components linked to abdominal obesity. Pearson correlation analysis showed strong positive correlations between waist circumference/height ratio, waist circumference, Cardiometabolic Index, and triglycerides. Weak positive correlations were observed between LDL-C, body mass index, and Cardiometabolic index, while a strong negative correlation was found between Cardiometabolic Index and HDL-C. ROC analysis indicated that the Cardiometabolic Index(CMI), Triglyceride-glucose(TyG) index, and waist circumference demonstrated the highest Area Under the Curve(AUC) values, indicating their efficacy in diagnosing metabolic syndrome. Optimal cut-off values were determined as >1.34, >8.86, and >84.5 for the Cardiometabolic Index, Triglyceride-glucose index, and waist circumference, respectively. Logistic regression analysis revealed significant differences for age(p=0.037), waist circumference(p<0.001), systolic blood pressure(p<0.001), triglycerides(p<0.001), LDL-C(p=0.028), fasting blood sugar(p<0.001), Cardiometabolic Index(p<0.001), and Triglyceride-glucose index (p<0.001). The odds ratios for these variables were 1.015, 1.179, 1.090, 3.03, and 69.16, respectively. In conclusion, the Cardiometabolic Index and Triglyceride-glucose index are robust predictive indicators closely associated with metabolic syndrome diagnosis, and waist circumference is identified as an excellent predictor. Integrating these variables into clinical practice holds the potential for enhancing early diagnosis and prevention of metabolic syndrome.
Abstract
This study investigates the utility of the Triglyceride-glucose(TyG) index and Cardiometabolic Index(CMI) as predictors for diagnosing metabolic syndrome. The study involved 1970 males, 1459 females, totaling 3429 participants who underwent health checkups at P Hospital in Busan between January 2023 and June 2023. Metabolic syndrome diagnosis was based on the presence of 3 or more risk factors out of the 5 criteria outlined by the American Heart Association/National Heart, Lung, and Blood Institute(AHA/NHLBI), and participants with 2 or fewer risk factors were categorized as normal. Statistical analyses included independent sample t-tests, chi-square tests, Pearson’s correlation analysis, Receiver Operating Characteristic(ROC) curve analysis, and logistic regression analysis, using the Statistical Package for the Social Sciences(SPSS) program. Significance was established at p<0.05. The comparison revealed that the metabolic syndrome group exhibited attributes such as advanced age, male gender, elevated systolic and diastolic blood pressures, high blood sugar, elevated triglycerides, reduced LDL-C, elevated HDL-C, higher Cardiometabolic Index, Triglyceride-glucose index, and components linked to abdominal obesity. Pearson correlation analysis showed strong positive correlations between waist circumference/height ratio, waist circumference, Cardiometabolic Index, and triglycerides. Weak positive correlations were observed between LDL-C, body mass index, and Cardiometabolic index, while a strong negative correlation was found between Cardiometabolic Index and HDL-C. ROC analysis indicated that the Cardiometabolic Index(CMI), Triglyceride-glucose(TyG) index, and waist circumference demonstrated the highest Area Under the Curve(AUC) values, indicating their efficacy in diagnosing metabolic syndrome. Optimal cut-off values were determined as >1.34, >8.86, and >84.5 for the Cardiometabolic Index, Triglyceride-glucose index, and waist circumference, respectively. Logistic regression analysis revealed significant differences for age(p=0.037), waist circumference(p<0.001), systolic blood pressure(p<0.001), triglycerides(p<0.001), LDL-C(p=0.028), fasting blood sugar(p<0.001), Cardiometabolic Index(p<0.001), and Triglyceride-glucose index (p<0.001). The odds ratios for these variables were 1.015, 1.179, 1.090, 3.03, and 69.16, respectively. In conclusion, the Cardiometabolic Index and Triglyceride-glucose index are robust predictive indicators closely associated with metabolic syndrome diagnosis, and waist circumference is identified as an excellent predictor. Integrating these variables into clinical practice holds the potential for enhancing early diagnosis and prevention of metabolic syndrome.
참고문헌 (28)
- Rodriguez-Colon SM, "Metabolic syndrome clusters and the risk of incident stroke : The atherosclerosis risk in communities(ARIC)study", Stroke, 40(1), pp.200~205 (2009)[DOI]
- Li R, "Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese", Journal of Diabetes Investigation, 9(2), pp.411~418 (2018)[DOI]
- Dunn FL, "Management of dyslipidemia in people with type 2 diabetes mellitus", Rev Endocr Metab Disord, 11(1), pp.41~51 (2010)[DOI]
- Cordero A, "Comparison of serum lipid values in subjects with and without the metabolic syndrome", Am J Cardiol, 102(4), pp.424~428 (2008)[DOI]
- 문신제, "The Cut-off Values of Triglycerides and Glucose Index for Metabolic Syndrome in American and Korean Adolescents", Journal of Korean Medical Science, 32(3), pp.427~433 (2017), 대한의학회
- Bonora E, "Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity : Studies in subjects with various degrees of glucose tolerance and insulin sensitivity", Diabetes Care, 23(1), pp.57~63 (2000)[DOI]
- Simental-Mendía LE, "The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects", Metabolic Syndrome and Related Disorders, 6(4), pp.299~304 (2008)[DOI]
- Guerrero-Romero F, "The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp", Journal of Clinical Endocrinology and Metabolism, 95(7), pp.3347~3351 (2010)[DOI]
- Hsieh SD, "Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity : Proposal to use the waist-to-height ratio", Prev Med, 42(4), pp.135~139 (2006)[DOI]
- Lee CMY, "Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI : A meta-analysis", Journal Clinical Epidemiology, 61(7), pp.646~653 (2008)[DOI]
- Ashwell M, "Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors : Systematic review and meta-analysis", Obes Rev, 13(3), pp.275~286 (2012)[DOI]
- Alberti KGMM, "The metabolic syndrome-a new worldwide definition", Lancet, 366(9491), pp.1059~1062 (2005)[DOI]
- 신경아, "Triglyceride and Glucose (TyG) Index is a Clinical Surrogate Marker for the Diagnosis of Metabolic Syndrome", 대한의생명과학회지, 23(4), pp.348~354 (2017), 대한의생명과학회[DOI]
- Western pacific region, international association for the study of obesity, and international obesity task force. The Asian-pacific perspective: Redefining obesity and its treatment, "World Health Organization", Health Communications Australia, ~ (2000)
- Grundy SM, "Diagnosis and management of the metabolic syndrome : An American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112(17), 2735~2752
- Muller MP, "Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?", Clinical Infectious Diseases, 40(8), pp.1079~1086 (2005)[DOI]
- Alberti KGMM, "Harmonizing the metabolic syndrome : A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120(16), pp.1640~1645 (2009)[DOI]
- Takahashi M, "A proposal of combined evaluation of waist circumference and BMI for the diagnosis of metabolic syndrome", Endocrine Journal, 56(9), pp.1079~1082 (2009)[DOI]
- Xu X, "Sex Differences in the TyG index and cardiovascular risk factors in metabolically obese normal weight phenotype", International Journal of Endocrinology, 24, pp.1139045~ (2022)[DOI]
- Manjuladevi MT, "Evaluation of novel metabolic indices and lipid ratios to identify metabolic syndrome in South Indians", Int J Med Rev Case Rep, 6(24), pp.24~29 (2022)[DOI]
- Lee SH, "Predicting the development of diabetes using the product of triglycerides and glucose : The Chungju Metabolic Disease Cohort(CMC)study", Public Library of Science One, 9(2), pp.e90430~ (2014)[DOI]
- David NG, "Triglyceride-glucose index(TyG index)in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose : The Vascular-Metabolic CUN cohort", Preventive Medicine, 86, pp.99~105 (2016)[DOI]
- Duan S, "Cardiometabolic index : A new predictor for metabolic associated fatty liver disease in Chinese adults", Front Endocrinol(Lausanne), 13, pp.1004855~ (2022)[DOI]
- Liu X, "Cardiometabolic index : A new tool for screening the metabolically obese normal weight phenotype", Journal of Endocrinological Investigation, 44(6), pp.1253~1261 (2021)[DOI]
- Sabarinathan M, "Correlation of cardiometabolic index and high sensitivity c reactive protein as obesity markers in metabolic syndrome patients-a case control study", Journal of Pharmaceutical Negative Results, 13(9), pp.9553~9561 (2022)[DOI]
- Ichiro W, "The “cardiometabolic index”as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus", Clinica Chimica Acta, 438(1), pp.274~278 (2015)[DOI]
- Lazzer S, "Cardiometabolic Index (CMI)and Visceral Adiposity Index (VAI) highlight a higher risk of metabolic syndrome in women with severe obesity", J. Clin. Med, 12(9), pp.3055~ (2023)[DOI]
